Literature DB >> 24082470

Assessment of oxidative stress and inflammatory process in patients of multiple myeloma.

Moushumi Lodh1, Binita Goswami, Nikhil Gupta, Surajeet K Patra, Alpana Saxena.   

Abstract

Multiple myeloma is a disseminated malignancy of monoclonal plasma cells that accounts for 15 % of all hematological cancers. The present study was conducted to evaluate the role of inflammation and oxidant-antioxidant dynamics in the etiology of this disease. The study population comprised of 20 cases of multiple myeloma and 20 healthy controls. The parameters evaluated were serum malondialdehyde (MDA), superoxide dismutase (SOD) and ferritin levels. The serum MDA levels were 1.9 ± 0.96 nmol/ml in cases as compared to 0.98 ± 0.55 nmol/ml in the controls. Similarly, a statistically significant difference was noted in the SOD and ferritin levels between the cases and controls (93.2 ± 23.8 vs. 210.1 ± 190.5 U/ml and 285.8 ± 216.4 vs. 131.8 ± 30.1 ng/ml respectively). Our study highlights the imbalance in the oxidant-anti oxidant mechanism and the role of smoldering inflammation in the etiology of multiple myeloma.

Entities:  

Keywords:  Antioxidants; Ferritin; Inflammation; Multiple myeloma; Oxidative stress; Superoxide dismutase (SOD); Thiobarbitone reactive substances (TBARS)

Year:  2012        PMID: 24082470      PMCID: PMC3477461          DOI: 10.1007/s12291-012-0222-y

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  13 in total

Review 1.  Free radicals, antioxidants, and human disease: where are we now?

Authors:  B Halliwell; J M Gutteridge; C E Cross
Journal:  J Lab Clin Med       Date:  1992-06

2.  An imbalance in oxidant/antioxidant dynamics: correlation with therapeutic response in patients with carcinoma of posterior one third of the tongue.

Authors:  Manoj Sharma; Medha Rajappa; Abhigyan Satyam; Alpana Sharma
Journal:  Oncol Res       Date:  2011       Impact factor: 5.574

Review 3.  Lipid peroxides and human diseases.

Authors:  K Yagi
Journal:  Chem Phys Lipids       Date:  1987 Nov-Dec       Impact factor: 3.329

4.  Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma.

Authors:  T Zima; I Spicka; S Stípek; J Crkovská; J Pláteník; M Merta; V Tesar
Journal:  Neoplasma       Date:  1996       Impact factor: 2.575

5.  Survival in multiple myeloma in Kerala.

Authors:  M K Nair; C Varghese; E Krishnan; R Sankaranarayanan; B Nair
Journal:  Natl Med J India       Date:  1993 Jan-Feb       Impact factor: 0.537

6.  Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia.

Authors:  Nuri Bakan; Seyithan Taysi; Omer Yilmaz; Ebubekir Bakan; Sevinç Kuşkay; Naim Uzun; Mehmet Gündoğdu
Journal:  Clin Chim Acta       Date:  2003-12       Impact factor: 3.786

Review 7.  Superoxide radical and superoxide dismutases.

Authors:  I Fridovich
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 8.  Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies.

Authors:  B Goswami; M Rajappa; M Sharma; A Sharma
Journal:  Int J Gynecol Cancer       Date:  2007-10-18       Impact factor: 3.437

Review 9.  Iron and carcinogenesis: from Fenton reaction to target genes.

Authors:  Shinya Toyokuni
Journal:  Redox Rep       Date:  2002       Impact factor: 4.412

10.  Elevation of serum ferritin is associated with the outcome of patients with newly diagnosed multiple myeloma.

Authors:  Moo-Kon Song; Joo-Seop Chung; Young-Mi Seol; Ho-Jin Shin; Young-Jin Choi; Goon-Jae Cho
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more
  2 in total

1.  Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma.

Authors:  Yousef Faridvand; Ali Eishi Oskuyi; Mohammad-Hassan Khadem-Ansari
Journal:  Redox Rep       Date:  2016-02-26       Impact factor: 4.412

2.  Myelomatous Pleural Effusion Presenting with Extreme Hyperferritinemia and Severe Inflammatory Response.

Authors:  Diego A Adrianzen Herrera; Matthew Scott; Mala Varma
Journal:  Case Rep Oncol       Date:  2015-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.